GLP-1 causes the body to produce more insulin, which is key to reducing glucose levels in the blood
Special Considerations for Women Over 40 or 50 While semaglutide produces similar results in women regardless of their age, those going through perimenopause or menopause may have additional health concerns to consider namely, the risk of muscle and bone loss
Central to the plaintiffs argument is the claim that these medications cause gastroparesis, while the defense contends that the drugs are designed to delay gastric emptying, which they argue is distinct from gastroparesis
A significant wave of patent and data protection expires in 2026 across eight key markets in wave 1: Canada, Brazil, China, India, Mexico , Turkey, Saudi Arabia* and South Africa (see Figure 1)
A recurring phone alarm or calendar event for your injection day prevents missed doses
While liraglutide requires daily injections (compared to the weekly dosing of semaglutide and tirzepatide), it remains a potential option for those seeking an alternative
